Skip to main content
. 2018 Jan 30;9(14):11559–11571. doi: 10.18632/oncotarget.24338

Figure 3. Percentage of patients with 5-FU AUC values below, within or above the therapeutic range for each cycle (black columns: cycle 1, white columns: cycle 2, dotted columns: cycle 3).

Figure 3